首页> 外文期刊>BMC Ophthalmology >Management of intraocular pressure elevation during hemodialysis of neovascular glaucoma: a case report
【24h】

Management of intraocular pressure elevation during hemodialysis of neovascular glaucoma: a case report

机译:新生血管性青光眼血液透析期间眼内压升高的处理:一例报告

获取原文
           

摘要

Background It is generally accepted that dialysis may lower plasma osmolality at a faster rate than changes in ocular osmolality. This osmotic difference causes water to migrate from the plasma into the aqueous humor, increasing intraocular pressure. Certain authors have described IOP increase in patients with narrow angles. Case presentation Here we report a neovascular glaucoma patient who experienced a substantial increase in IOP associated with severe eye pain and blurred vision during sessions of dialysis. The patient had been refractory to several antiglaucoma drugs and improved after intravenous administration of 20?% hyperosmotic glucose solution with dialysis and pan-retinal photocoagulation. Conclusion It is the first report in which intravenous glucose administration and reduction of neovascularization by argon laser pan-retinal photocoagulation successfully managed IOP increase during dialysis in neovascular glaucoma. Further clinical studies are required to confirm our results.
机译:背景技术人们普遍认为透析可以比眼渗透压的变化更快地降低血浆渗透压。这种渗透性差异导致水从血浆迁移到房水中,从而增加了眼内压。某些作者描述了狭窄角度患者的眼压增加。病例介绍我们在这里报告了一个新生血管性青光眼患者,在透析期间,IOP显着增加,伴有严重的眼痛和视力模糊。该患者对几种抗青光眼药物均无效,并且在静脉内给予20%的高渗葡萄糖溶液进行透析和全视网膜光凝治疗后有所改善。结论这是首次报道静脉输注葡萄糖并通过氩激光全视网膜光凝术减少新生血管性青光眼透析期间IOP的升高。需要进一步的临床研究以证实我们的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号